-
Post date
June 29, 2022
-
Posted by
Kieran Robertson
-
Posted in
Ecstasy, Health Canada approval, Health Canada restricted drug amendments, Mushrooms, OPTI.C, Optimi, Optimi Health, Optimi Health Corp., psilocybin, psychedelic assisted therapy, psychedelic drug market, Psychedelics, SABI Mind, SAP, Special Access Program
-
Post date
June 29, 2022
-
Posted by
Kieran Robertson
-
Posted in
Ecstasy, Health Canada approval, Health Canada restricted drug amendments, Mushrooms, OPTI.C, Optimi, Optimi Health, Optimi Health Corp., psilocybin, psychedelic assisted therapy, psychedelic drug market, Psychedelics, SABI Mind, SAP, Special Access Program
-
Post date
April 27, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelics companies, best psychedelics stocks 2021, FH.NE, Filament, Filament Health, Filament Health (FH.NE), filament health clinical trials, filament health ipo, Filament Health Natural Psychedelic, Filament Health Trials, filament stock, invest in psychedelics, mental health, mental health psychedelics, Mushrooms, Psilo Scientific, psilocybin, psychedelic assisted therapy, Psychedelics
-
Post date
January 26, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelic treatment, clinical trials psilocybin 2021, Filament, Filament Health, Filament Health (FH.NE), filament health clinical trials, Filament Health Natural Psychedelic, Filament Health Trials, medicinal psilocybin, Mushrooms, pharmaceutical grade psilocybin, pharmaceutical psilocybin, Psilo Scientific, psilocybin, psilocybin aided therapies, psilocybin based therapies, psilocybin clinical trials, psilocybin companies, psilocybin market, psilocybin mushrooms, psilocybin studies, psilocybin study, psychedelic assisted therapy, Psychedelics, psychedelics assisted therapeutics
-
Post date
January 25, 2022
-
Posted by
Kieran Robertson
-
Posted in
best psychedelic companies, best psychedelic stocks, best psychedelic treatment, clinical trials psychedelics, companies doing psychedelics research, GAD, Generalized Anxiety Disorder, investing in psychedelics, LSD, LSD research, Major depressive disorder, MDD, medical psychedelics, Mind Medicine, Mind Medicine Inc., MindMEd, MNMD.Q, psychedelic assisted therapy, psychedelic market, Psychedelics, psychedelics stocks, therapy for major depression disorder
